Skip to content

Comparing the effect of receiving antibiotics in reducing infections after cesarean section

Comparing the effect of receiving an antibiotic regimen of clindamycin and cephalexin with clindamycin and cefazolin in reducing infections after elective cesarean section in patients with a BMI greater than 30

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250414065321N1
Enrollment
110
Registered
2025-07-30
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean. Single liveborn infant, delivered by cesarean

Interventions

Intervention 1: Intervention group: Patients will be assigned to both groups according to the random sequence generated in the Randomization Main software, which is reported in Table (1) on the next p

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient consent Women with a gestational age of more than 38 weeks who undergo elective cesarean section Patients with a BMI greater than or equal to 30

Exclusion criteria

Exclusion criteria: Emergency cesarean section (meconium tic, ruptured membranes, preeclampsia, etc.) Immunocompromised patients, patients with renal failure? Patients who are allergic to cefazolin or clindamycin or cephalexin Patients who have recently received an antibiotic regimen within the last three months Diabetic patients or a history of GDM

Design outcomes

Primary

MeasureTime frame
Infection. Timepoint: After 6 weeks of visit. Method of measurement: According to the SIRS criteria, they have at least two of the four SIRS criteria (body temperature above 38 degrees or below 36 degrees Celsius, heart rate above 90 beats per minute, respiratory rate above 20 beats per minute, WBC count above 12,000 or below 4,000 cells per microliter).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nazanin Abdi

Bandare-abbas University of Medical Sciences

info@hums.ac.ir+98 76 3333 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026